THE INFLUENCE OF CRYOPRESERVED PLACENTAL EXPLANTS ON OVARIES AND UTERUS RECOVERY AFTER PELVIC INFLAMMATORY DISEASE IN THE EXPERIMENT
Pelvic inflammatory disease is the most common gynecological pathology. A number of studies have demonstrated the effectiveness of placenta derivatives for the female genital system pathology treatment.
The aim of the study was to determine the effect of cryopreserved placenta explants on ovaries and uterus recovery after an infectious process.
Materials and methods: Inflammation was modeled on non-linear mice by the method of puncture and ligation of the cecum, followed by antibiotic therapy. For rehabilitation, intramuscular injection of cryopreserved placenta explants of 10 mg per animal was used. The numbers of ovarian generative elements, the structure of uterus, the severity of adhesions, reproductive indices in experimental animals were studied.
The results of the study and their discussion: It was found that the modeling of the infectious process leads to an increasing of adhesions formation, a decreasing of the primordial and primary follicles number, folliculogenesis suppression, a number of pregnant animals and fetuses decreasing. The placental explants application has no effect on uterine adhesions, leads to a number of all follicles increasing (except for primordial ones), number of fetuses increasing, but not the number of pregnant mice.
Conclusion: The cryopreserved placental explants application after the cured infectious process does not affect adhesion formation, leads to the stimulation of folliculogenesis, uterine hypertrophy and improvement of reproductive indices due to an increasing in the number of fetuses
2. Romashchenko OV, Vozianova SV, Rudenko AV, Yakovenko LF. Treatment of inflammatory diseases of the pelvic organs caused by mixed infection. Woman's health. 2016;112(6):134–40.
3. Das BB, Ronda J, Trent M. Pelvic inflammatory disease: improving awareness, prevention, and treatment. Infect Drug Resist. 2016;9:191-7. doi: 10.2147/IDR.S91260.
4. Grishchenko NG, Klimenko NA, Gorgol NI, Tatarko SV. The influence of placenta cryoextract on the course of chronic ovarian inflammation in mice. Medicine today and tomorrow. 2010;2(3):7–17.
5. Pitko VA, Subota NP. Effect of chorionic cryoextract on immunity in women with subacute pelvic inflammatory disease. Probl Cryobiol Cryomed. 2000;1:76–80.
6. Pitko VA, Klimenko MO, Subota NP, Tatarko SV. Comparative characteristics of the anti-inflammatory action of chorionic and placental extracts. Physical journal. 2000;46(1):32–6.
7. Prokopyuk VYu, Grischenko OV, Prokopyuk OV, Shevchenko NO, Falko OV, Storchak AV, Schedrov AO. Effect of cryopreserved placental explants on female reproductive system under normal and pathological conditions (experimental study). Probl Cryobiol Cryomed. 2017;28(3):250–65. DOI: https://doi.org/10.15407%2Fcryo27.03.250
8. Pogozhykh O, Prokopyuk V, Figueiredo C, Pogozhykh D. Placenta and placental derivatives in regenerative therapies: experimental studies, history, and prospects. Stem Cells International. 2018;14. doi:10.1155/2018/4837930
9. Silini AR, Cargnoni A, Magatti M, Pianta S, Parolini O. The long path of human placenta, and its derivatives, in regenerative medicine. Front Bioeng Biotechnol. 2015;3:162. DOI: 10.3389/fbioe.2015.00162
10. Prokopiuk VYu. Influence of media conditioned by cryopreserved and fresh placental explants and cells on murine uterine and ovarian organotypic cultures. Probl Cryobiol Cryomed. 2018; 28(2): 139–150.
11. Giwa S, Lewis JK, Alvarez L, Langer R, Roth AE, Church GM, et al. The promise of organ and tissue preservation to transform medicine. Nat Biotechnol. 2017;35(6):530–42. DOI: 10.1038/nbt.3889
12. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 2009;4(1):31–6.
13. Stefanov OV, redaktor. Doklinichni doslidzhennya likarskikh zasobiv: metod. rekomendatsii. Kyiv: Avitsena, 2001. 528 р. [in Ukrainian].